INR 106.04
(1.49%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 389.89 Million INR | -49.91% |
2022 | 1.1 Billion INR | 14.56% |
2021 | 968.2 Million INR | 25.51% |
2020 | 771.39 Million INR | -9.65% |
2019 | 853.75 Million INR | -3.83% |
2018 | 887.76 Million INR | -4.56% |
2017 | 930.23 Million INR | -5.9% |
2016 | 988.59 Million INR | 21.76% |
2015 | 811.94 Million INR | 9.2% |
2014 | 743.54 Million INR | 5.46% |
2013 | 705.02 Million INR | 23.0% |
2012 | 573.18 Million INR | 9.87% |
2011 | 521.7 Million INR | 14.51% |
2010 | 455.59 Million INR | 4.49% |
2009 | 436.01 Million INR | 4.58% |
2008 | 416.93 Million INR | 17.0% |
2007 | 356.36 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 139.08 Million INR | -11.03% |
2023 Q1 | 266.56 Million INR | -0.31% |
2023 Q2 | 339.49 Million INR | 27.36% |
2023 Q3 | 309.84 Million INR | -8.73% |
2023 Q4 | 156.31 Million INR | -49.55% |
2023 FY | 555.62 Million INR | -49.91% |
2022 FY | 1.1 Billion INR | 14.56% |
2022 Q4 | 267.39 Million INR | -4.62% |
2022 Q3 | 280.33 Million INR | -6.46% |
2022 Q2 | 299.69 Million INR | 19.4% |
2022 Q1 | 250.99 Million INR | 8.86% |
2021 Q4 | 230.57 Million INR | -7.99% |
2021 Q3 | 250.59 Million INR | -7.66% |
2021 Q2 | 271.36 Million INR | 38.08% |
2021 FY | 968.2 Million INR | 25.51% |
2021 Q1 | 196.52 Million INR | 4.23% |
2020 Q2 | 183.24 Million INR | -5.08% |
2020 FY | 771.39 Million INR | -9.65% |
2020 Q3 | 221.48 Million INR | 20.87% |
2020 Q4 | 188.54 Million INR | -14.87% |
2020 Q1 | 193.04 Million INR | 16.88% |
2019 FY | 853.75 Million INR | -3.83% |
2019 Q2 | 235.61 Million INR | 1.24% |
2019 Q1 | 232.71 Million INR | 27.77% |
2019 Q3 | 213.31 Million INR | -9.46% |
2019 Q4 | 165.16 Million INR | -22.57% |
2018 Q4 | 182.13 Million INR | -14.1% |
2018 Q2 | 271.62 Million INR | 28.1% |
2018 FY | 887.76 Million INR | -4.56% |
2018 Q1 | 212.04 Million INR | -24.54% |
2018 Q3 | 212.04 Million INR | -21.94% |
2017 FY | 930.23 Million INR | -5.9% |
2017 Q4 | 281.01 Million INR | 0.0% |
2016 Q3 | 270.56 Million INR | 0.22% |
2016 FY | 988.59 Million INR | 21.76% |
2016 Q4 | 327.03 Million INR | 20.87% |
2016 Q2 | 269.97 Million INR | 28.77% |
2016 Q1 | 209.65 Million INR | -13.48% |
2015 Q4 | 242.3 Million INR | 4.53% |
2015 FY | 811.94 Million INR | 9.2% |
2015 Q1 | 242.3 Million INR | 4.57% |
2015 Q2 | 217.9 Million INR | -10.07% |
2015 Q3 | 231.8 Million INR | 6.38% |
2014 Q1 | 176.74 Million INR | -6.08% |
2014 Q4 | 231.71 Million INR | 29.73% |
2014 Q3 | 178.62 Million INR | -5.3% |
2014 FY | 743.54 Million INR | 5.46% |
2014 Q2 | 188.61 Million INR | 6.72% |
2013 Q1 | 168.55 Million INR | 8.98% |
2013 Q4 | 188.18 Million INR | 8.76% |
2013 FY | 705.02 Million INR | 23.0% |
2013 Q2 | 175.26 Million INR | 3.98% |
2013 Q3 | 173.02 Million INR | -1.28% |
2012 Q2 | 136.82 Million INR | 2.32% |
2012 Q1 | 133.71 Million INR | -9.59% |
2012 Q3 | 140.31 Million INR | 2.55% |
2012 Q4 | 154.66 Million INR | 10.23% |
2012 FY | 573.18 Million INR | 9.87% |
2011 Q3 | 129.68 Million INR | -0.94% |
2011 Q4 | 147.91 Million INR | 14.06% |
2011 FY | 521.7 Million INR | 14.51% |
2011 Q2 | 130.91 Million INR | 0.0% |
2010 FY | 455.59 Million INR | 4.49% |
2009 FY | 436.01 Million INR | 4.58% |
2008 FY | 416.93 Million INR | 17.0% |
2007 FY | 356.36 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.747% |
NATCO Pharma Limited | 10.05 Billion INR | 96.124% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 72.206% |
Syncom Formulations (India) Limited | 942.39 Million INR | 58.628% |
Achyut Healthcare Limited | 1.6 Million INR | -24131.821% |
Ajanta Pharma Limited | 30.46 Billion INR | 98.72% |
Alkem Laboratories Limited | 32.83 Billion INR | 98.813% |
Alpa Laboratories Limited | 156.14 Million INR | -149.694% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 97.543% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 85.007% |
Aurobindo Pharma Limited | 39.23 Billion INR | 99.006% |
Bajaj HealthCare Limited | 985.34 Million INR | 60.431% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 72.528% |
Brooks Laboratories Limited | 51.18 Million INR | -661.801% |
Divi's Laboratories Limited | 14.17 Billion INR | 97.248% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.593% |
Eris Lifesciences Limited | 4.94 Billion INR | 92.112% |
FDC Limited | 5.34 Billion INR | 92.71% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.423% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 96.651% |
Granules India Limited | 7.18 Billion INR | 94.572% |
Gufic Biosciences Limited | 1.07 Billion INR | 63.822% |
Hester Biosciences Limited | 908.84 Million INR | 57.1% |
Indoco Remedies Limited | 4.74 Billion INR | 91.79% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 81.645% |
Ipca Laboratories Limited | 13.91 Billion INR | 97.198% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 49.588% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -744.722% |
Lasa Supergenerics Limited | 291.17 Million INR | -33.903% |
Laurus Labs Limited | 3.01 Billion INR | 87.05% |
Lupin Limited | 95.67 Billion INR | 99.592% |
Mankind Pharma Limited | 23.15 Billion INR | 98.316% |
Medicamen Biotech Limited | 335.16 Million INR | -16.327% |
Medico Remedies Limited | 161.84 Million INR | -140.905% |
Megasoft Limited | 49.52 Million INR | -687.211% |
Piramal Pharma Limited | 19.91 Billion INR | 98.042% |
RPG Life Sciences Limited | 1.63 Billion INR | 76.161% |
Sigachi Industries Limited | 579.88 Million INR | 32.764% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 87.328% |
Unichem Laboratories Limited | 6.72 Billion INR | 94.203% |
Wanbury Limited | 1.16 Billion INR | 66.416% |
Windlas Biotech Limited | 1 Billion INR | 61.263% |
ZIM Laboratories Limited | 1.01 Billion INR | 61.514% |
Zydus Lifesciences Limited | 43.17 Billion INR | 99.097% |
Procter & Gamble Health Limited | 2.99 Billion INR | 86.984% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 64.523% |
Strides Pharma Science Limited | 9.16 Billion INR | 95.745% |
Venus Remedies Limited | 1.91 Billion INR | 79.654% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 87.318% |
Nectar Lifesciences Limited | 625.55 Million INR | 37.672% |
Shilpa Medicare Limited | 2.18 Billion INR | 82.12% |
Aarti Drugs Limited | 1.16 Billion INR | 66.604% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 64.517% |
Suven Life Sciences Limited | 109.75 Million INR | -255.253% |
Ind-Swift Limited | 946.56 Million INR | 58.81% |
Valiant Laboratories Limited | 36.28 Million INR | -974.403% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 95.368% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 91.487% |
Themis Medicare Limited | 782.85 Million INR | 50.196% |
Hikal Limited | 2.48 Billion INR | 84.319% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 98.18% |
Sequent Scientific Limited | 2.9 Billion INR | 86.564% |
Novartis India Limited | 470.1 Million INR | 17.062% |
Wockhardt Limited | 6.4 Billion INR | 93.908% |
Jubilant Pharmova Limited | 14.45 Billion INR | 97.303% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -2305.288% |
Neuland Laboratories Limited | 2.92 Billion INR | 86.692% |
Morepen Laboratories Limited | 1.98 Billion INR | 80.382% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 5.464% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 42.337% |